Patents by Inventor Gernot Warnke

Gernot Warnke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925707
    Abstract: The present invention is directed to a co-processed lubricant excipient which can be used to manufacture tablets, and pharmaceutical compositions containing the same.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: March 12, 2024
    Assignee: JRS Pharma GMBH & CO. KG
    Inventors: Sabine Wetzel, Tobias Goetz, Gernot Warnke
  • Publication number: 20220287974
    Abstract: The present invention is directed to a co-processed lubricant excipient which can be used to manufacture tablets, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: March 15, 2021
    Publication date: September 15, 2022
    Applicant: JRS Pharma GmbH & Co. KG
    Inventors: Sabine WETZEL, Tobias GOETZ, Gernot WARNKE
  • Patent number: 8663684
    Abstract: The present invention concerns a process for producing a granulate based on lactose and cellulose (derivative), a granulate obtainable by the process and its use as a tabletting excipient.
    Type: Grant
    Filed: September 21, 2009
    Date of Patent: March 4, 2014
    Assignee: Molkerei Meggle Wasserburg GmbH & Co. KG
    Inventors: Eugen Schwarz, Gernot Warnke, Vera Fichtner
  • Publication number: 20110207826
    Abstract: The present invention concerns a process for producing a granulate based on lactose and cellulose (derivative), a granulate obtainable by the process and its use as a tabletting excipient.
    Type: Application
    Filed: September 21, 2009
    Publication date: August 25, 2011
    Inventors: Eugen Schwarz, Gernot Warnke, Vera Fichtner
  • Patent number: 6090955
    Abstract: The aim of the invention is to produce liposome-encapsulated taxol with a high taxol concentration and high stability and hence a high therapeutic effect. The invention involves the development of specific forms of taxol encapsulation and the use of these, optionally in combination with other substances, in the treatment of various types of tumor. The liposome-encapsulated taxol is characterized in that it is prepared by high-pressure homogenization or by aerosol formulation.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: July 18, 2000
    Assignee: Max-Delbruck-Centrum fur Molekulare Medizin
    Inventors: Regine Reszka, Martin Brandl, Iduna Fichtner, Gernot Warnke